4DNBS93GDP1U
released
May 10th, 2018 at 6:35pm
Overview
Stable Genomic Modifications
None
Treatment
Tamoxifen treatment (10.0 mg/mL, 5.0d)
(Chemical)
Biosample Protocols
Biosource
Biosource
Biosource Type
Primary cell
Cell Line Name
Individual
Biosource Vendor
None